Industry Posters (Non-CE)
Evaluation of Cannabidiol Product-labeling Accuracy and Contaminants Among Commercially Sourced Products
Authors: Barry E. Gidal1; Ryan Vandrey; Chela Wallin; Sean Callan; Alan Sutton; Timothy B. Saurer; Jennifer Triemstra
Sponsored by
RAISE Trial: Randomized Therapy in Status Epilepticus
Author: Marinus Pharmaceuticals, Inc.
Sponsored by
Anticholinergics Should Not Be Used to Treat Tardive Dyskinesia: Insights from an Expert Panel of Psychiatry and Neurology Healthcare Professionals
Authors: Nora Vanegas-Arroyave, Dawn Vanderhoef, Rachel Manahan, Samantha Cicero
Sponsored by
Please forward all questions regarding our posters to medinfo@neurocrine.com.
Treatment Success and Psychiatric Stability in Adults with Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies
Authors: Andrew J. Cutler, Rakesh Jain, Alon Bloom, Scott Siegert, Leslie Lundt, Celia Zinger
Sponsored by
Please forward all questions regarding our posters to medinfo@neurocrine.com.
Understanding the Continuing Educational Needs of US Clinicians Managing “OFF” Episodes in Parkinson’s Disease
Authors: Shereta Wiley, Wendy Cerenzia1, Sylvie Stacy, MD, Brandon Coleman, Khody Farahmand, Eric Jen
Sponsored by
Please forward all questions regarding our posters to medinfo@neurocrine.com.